ADIENT ($ADNT) posted quarterly earnings results for Q1 2026 on Wednesday, February 4th. The company reported earnings of $0.35 per share, beating estimates of $0.23 by $0.12. The company also reported revenue of $3,644,000,000, beating estimates of $3,585,318,135 by $58,681,865.
You can see Quiver Quantitative's $ADNT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ADIENT Insider Trading Activity
ADIENT insiders have traded $ADNT stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $ADNT stock by insiders over the last 6 months:
- JEROME J. DORLACK (President and CEO) sold 12,000 shares for an estimated $273,240
- MICHEL PIERRE ROSE BERTHELIN (EVP, EMEA) sold 2,500 shares for an estimated $49,275
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ADIENT Hedge Fund Activity
We have seen 116 institutional investors add shares of ADIENT stock to their portfolio, and 134 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 1,839,894 shares (-27.0%) from their portfolio in Q3 2025, for an estimated $44,304,647
- GOLDMAN SACHS GROUP INC added 1,140,714 shares (+102.6%) to their portfolio in Q3 2025, for an estimated $27,468,393
- QUANTEDGE CAPITAL PTE LTD added 1,036,111 shares (+4317.1%) to their portfolio in Q3 2025, for an estimated $24,949,552
- BLACKROCK, INC. removed 953,103 shares (-6.0%) from their portfolio in Q3 2025, for an estimated $22,950,720
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 718,538 shares (+61.3%) to their portfolio in Q3 2025, for an estimated $17,302,395
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 684,880 shares (-21.1%) from their portfolio in Q3 2025, for an estimated $16,491,910
- ROYAL BANK OF CANADA added 607,950 shares (+502.8%) to their portfolio in Q3 2025, for an estimated $14,639,435
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ADIENT Analyst Ratings
Wall Street analysts have issued reports on $ADNT in the last several months. We have seen 2 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 01/12/2026
- Stifel issued a "Buy" rating on 11/06/2025
- B of A Securities issued a "Underperform" rating on 09/10/2025
- Morgan Stanley issued a "Underweight" rating on 08/12/2025
To track analyst ratings and price targets for ADIENT, check out Quiver Quantitative's $ADNT forecast page.
ADIENT Price Targets
Multiple analysts have issued price targets for $ADNT recently. We have seen 8 analysts offer price targets for $ADNT in the last 6 months, with a median target of $24.5.
Here are some recent targets:
- Nathan Janes from Stifel set a target price of $26.0 on 01/23/2026
- Dan Levy from Barclays set a target price of $25.0 on 01/23/2026
- Joseph Spak from UBS set a target price of $30.0 on 01/14/2026
- Colin Langan from Wells Fargo set a target price of $29.0 on 01/12/2026
- Adam Jonas from Morgan Stanley set a target price of $20.0 on 12/08/2025
- Michael Ward from Citigroup set a target price of $22.5 on 11/12/2025
- Ryan Brinkman from JP Morgan set a target price of $24.0 on 11/06/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
